Skip to main content

Corporate insider profile

John Charles Thomas Insider Trades

John Charles Thomas has reported no open-market purchases on SEC Form 4 and is a net seller of $541,173 across 1 company. The most recent open-market transaction was reported on Jun 25, 2026. Source: SEC Form 4 filings.

Latest reported as EVP, General Counsel of Krystal Biotech, Inc. (KRYS).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$541,173.26
Latest transaction
Jun 25, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 25, 2026Krystal Biotech, Inc. (KRYS)EVP, General CounselSale1,000$347.27$347,270
May 26, 2026Krystal Biotech, Inc. (KRYS)EVP, General CounselSale642$302.03$193,903

Common questions

John Charles Thomas insider trading FAQ

Is John Charles Thomas buying or selling stock?
Across all SEC Form 4 open-market filings on record, John Charles Thomas is a net seller of $541,173, with no open-market purchases reported. The latest transaction was reported on Jun 25, 2026.
Which companies does John Charles Thomas report insider trades for?
John Charles Thomas has reported open-market trades in Krystal Biotech, Inc. (KRYS). The latest SEC-reported relationship is EVP, General Counsel of Krystal Biotech, Inc. (KRYS).
Where does John Charles Thomas's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 2114900, and refreshes this page daily.